These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 23288633)

  • 81. Development of Small Molecules Targeting the Wnt Signaling Pathway in Cancer Stem Cells for the Treatment of Colorectal Cancer.
    Song L; Li Y; He B; Gong Y
    Clin Colorectal Cancer; 2015 Sep; 14(3):133-45. PubMed ID: 25799881
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Translation initiation in colorectal cancer.
    Parsyan A; Hernández G; Meterissian S
    Cancer Metastasis Rev; 2012 Jun; 31(1-2):387-95. PubMed ID: 22418835
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Novel and Emerging Targeted Therapies of Colorectal Cancer.
    Finnberg N; Gokare P; El-Deiry WS
    Curr Clin Pharmacol; 2015; 10(4):279-98. PubMed ID: 26548905
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Pharmacogenomics of intrinsic and acquired pharmacoresistance in colorectal cancer: Toward targeted personalized therapy.
    De Mattia E; Cecchin E; Toffoli G
    Drug Resist Updat; 2015 May; 20():39-70. PubMed ID: 26027741
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Epidermal growth factor receptor: pathway, therapies, and pipeline.
    Goffin JR; Zbuk K
    Clin Ther; 2013 Sep; 35(9):1282-303. PubMed ID: 24054705
    [TBL] [Abstract][Full Text] [Related]  

  • 86. BRAF in metastatic colorectal cancer: the future starts now.
    Orlandi A; Calegari A; Inno A; Berenato R; Caporale M; Niger M; Bossi I; Di Bartolomeo M; de Braud F; Pietrantonio F
    Pharmacogenomics; 2015 Dec; 16(18):2069-81. PubMed ID: 26615988
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Colorectal cancer models for novel drug discovery.
    Golovko D; Kedrin D; Yilmaz ÖH; Roper J
    Expert Opin Drug Discov; 2015; 10(11):1217-29. PubMed ID: 26295972
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Oncogenic role and therapeutic target of leptin signaling in colorectal cancer.
    Zhou W; Tian Y; Gong H; Guo S; Luo C
    Expert Opin Ther Targets; 2014 Aug; 18(8):961-71. PubMed ID: 24946986
    [TBL] [Abstract][Full Text] [Related]  

  • 89. The role of the PI3K pathway in colorectal cancer.
    Papadatos-Pastos D; Rabbie R; Ross P; Sarker D
    Crit Rev Oncol Hematol; 2015 Apr; 94(1):18-30. PubMed ID: 25591826
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The implications of colorectal cancer molecular biology in clinical practice.
    Kargozaran H; Kahlenberg M; Khatri VP
    Surg Oncol Clin N Am; 2008 Apr; 17(2):341-55, viii-ix. PubMed ID: 18375356
    [TBL] [Abstract][Full Text] [Related]  

  • 91. From Molecular Biology to Clinical Trials: Toward Personalized Colorectal Cancer Therapy.
    Palma S; Zwenger AO; Croce MV; Abba MC; Lacunza E
    Clin Colorectal Cancer; 2016 Jun; 15(2):104-15. PubMed ID: 26777471
    [TBL] [Abstract][Full Text] [Related]  

  • 92. On target? Strategies and progress in the development of therapies for colorectal cancer targeted against WNT signalling.
    McDonald SL; Silver AR
    Colorectal Dis; 2011 Apr; 13(4):360-9. PubMed ID: 20015264
    [TBL] [Abstract][Full Text] [Related]  

  • 93. New strategies for colorectal cancer prevention and treatment.
    Saha D; Roman C; Beauchamp RD
    World J Surg; 2002 Jul; 26(7):762-6. PubMed ID: 11948369
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Apoptosis and colorectal cancer: implications for therapy.
    Yang SY; Sales KM; Fuller B; Seifalian AM; Winslet MC
    Trends Mol Med; 2009 May; 15(5):225-33. PubMed ID: 19362056
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Molecular therapy of colorectal cancer: progress and future directions.
    Weng W; Feng J; Qin H; Ma Y
    Int J Cancer; 2015 Feb; 136(3):493-502. PubMed ID: 24420815
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Promising targets and drugs in development for colorectal cancer.
    Thompson C; Leong S; Messersmith W
    Semin Oncol; 2011 Aug; 38(4):588-97. PubMed ID: 21810518
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Targeting PI3K signaling as a therapeutic approach for colorectal cancer.
    Zhang J; Roberts TM; Shivdasani RA
    Gastroenterology; 2011 Jul; 141(1):50-61. PubMed ID: 21723986
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Integration of biologic agents with cytotoxic chemotherapy in metastatic colorectal cancer.
    Jain VK; Hawkes EA; Cunningham D
    Clin Colorectal Cancer; 2011 Dec; 10(4):245-57. PubMed ID: 21729675
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Targeted nanoparticles for colorectal cancer.
    Cisterna BA; Kamaly N; Choi WI; Tavakkoli A; Farokhzad OC; Vilos C
    Nanomedicine (Lond); 2016 Sep; 11(18):2443-56. PubMed ID: 27529192
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Oxaliplatin-based chemotherapy in the management of colorectal cancer.
    Capdevila J; Elez E; Peralta S; Macarulla T; Ramos FJ; Tabernero J
    Expert Rev Anticancer Ther; 2008 Aug; 8(8):1223-36. PubMed ID: 18699761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.